Real-time enrollment status for this heart failure with preserved ejection fraction clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 9:51 AM UTC
| NCT Number | NCT07795814 |
| Recruiting Status | Recruiting |
| Condition | Heart Failure With Preserved Ejection Fraction |
| Phase | PHASE2 |
| Target Enrollment | 90 participants |
| Active Locations | 28 sites in the US |
| Sponsor | Edgewise Therapeutics, Inc. |
| Last Updated on CT.gov | October 13, 2026 (3 days ago) |
As of October 16, 2026: Clinical trial NCT07795814 is currently recruiting participants. This phase2 study for heart failure with preserved ejection fraction is actively seeking new participants at 28 locations across the United States. The study is sponsored by Edgewise Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07795814 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 28 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07795814 was last updated 3 days ago (October 13, 2026). HelloStudys verifies this status automatically.